| Silent non-alcoholic fatty liver disease—a clinical–histological study P Sorrentino, G Tarantino, P Conca, A Perrella, ML Terracciano, ... Journal of hepatology 41 (5), 751-757, 2004 | 252 | 2004 |
| Role of quercetin (a natural herbal compound) in allergy and inflammation. YB Shaik, ML Castellani, A Perrella, F Conti, V Salini, S Tete, ... Journal of biological regulators and homeostatic agents 20 (3-4), 47-52, 2006 | 170 | 2006 |
| Role of mast cells in tumor growth P Conti, ML Castellani, D Kempuraj, V Salini, J Vecchiet, S Tetè, ... Annals of Clinical & Laboratory Science 37 (4), 315-322, 2007 | 151 | 2007 |
| Editorial–Novel Coronavirus 2019 (Sars-CoV2): a global emergency that needs new approaches A Perrella, N Carannante, M Berretta, M Rinaldi, N Maturo, L Rinaldi Eur Rev Med Pharmaco 24, 2162-2164, 2020 | 87 | 2020 |
| Preservation of nutritional‐status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis P Sorrentino, G Castaldo, L Tarantino, A Bracigliano, A Perrella, ... Journal of gastroenterology and hepatology 27 (4), 813-822, 2012 | 79 | 2012 |
| Risk of hepatocellular carcinoma after HCV clearance by direct-acting antivirals treatment predictive factors and role of epigenetics L Rinaldi, R Nevola, G Franci, A Perrella, G Corvino, A Marrone, ... Cancers 12 (6), 1351, 2020 | 78 | 2020 |
| IL-32: a newly-discovered proinflammatory cytokine. P Felaco, ML Castellani, MA De Lutiis, M Felaco, F Pandolfi, V Salini, ... Journal of biological regulators and homeostatic agents 23 (3), 141-147, 2009 | 74 | 2009 |
| Anti-chemokine therapy for inflammatory diseases ML Castellani, K Bhattacharya, M Tagen, D Kempuraj, A Perrella, ... International Journal of Immunopathology and Pharmacology 20 (3), 447-453, 2007 | 73 | 2007 |
| A clinical–morphological study on cholestatic presentation of nonalcoholic fatty liver disease P Sorrentino, G Tarantino, A Perrella, P Micheli, O Perrella, P Conca Digestive diseases and sciences 50 (6), 1130-1135, 2005 | 67 | 2005 |
| Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans M Manangeeswaran, J Jacques, C Tami, K Konduru, N Amharref, ... Gastroenterology 142 (7), 1516-1525. e3, 2012 | 65 | 2012 |
| Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study L Rinaldi, A Perrella, M Guarino, M De Luca, G Piai, N Coppola, ... Journal of Translational Medicine 17, 1-10, 2019 | 63 | 2019 |
| Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis P Sorrentino, L Terracciano, S D’Angelo, U Ferbo, A Bracigliano, ... Journal of gastroenterology 45, 1053-1062, 2010 | 57 | 2010 |
| Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study R Galiero, PC Pafundi, V Simeon, L Rinaldi, A Perrella, E Vetrano, ... PloS one 15 (12), e0243700, 2020 | 55 | 2020 |
| Transforming growth factor beta-1 and interferon-alpha in the aids dementia complex: possible relationship with cerebral viral load? O Perrella, PB Carreiri, A Perrella, C Sbreglia, F Gorga, D Guarnaccia, ... European cytokine network 12 (1), 51-5, 2001 | 54 | 2001 |
| Role of liver stiffness measurement in predicting HCC occurrence in direct-acting antivirals setting: a real-life experience L Rinaldi, M Guarino, A Perrella, PC Pafundi, G Valente, L Fontanella, ... Digestive diseases and sciences 64, 3013-3019, 2019 | 51 | 2019 |
| Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes FC Sasso, PC Pafundi, A Caturano, R Galiero, E Vetrano, R Nevola, ... Nutrition, Metabolism and Cardiovascular Diseases 31 (8), 2345-2353, 2021 | 47 | 2021 |
| Invasive aspergillosis in solid organ transplant patients: diagnosis, prophylaxis, treatment, and assessment of response D Neofytos, C Garcia-Vidal, F Lamoth, C Lichtenstern, A Perrella, ... BMC infectious diseases 21, 1-11, 2021 | 42 | 2021 |
| Autism and immunity: revisited study ML Castellani, CM Conti, DJ Kempuraj, V Salini, J Vecchiet, S Tetè, ... International Journal of Immunopathology and Pharmacology 22 (1), 15-19, 2009 | 37 | 2009 |
| Endometrial polyps in infertile patients: do high concentrations of interferon-gamma play a role? A Mollo, A Stile, C Alviggi, M Granata, G De Placido, A Perrella, ... Fertility and sterility 96 (5), 1209-1212, 2011 | 36 | 2011 |
| The latest interleukin: IL-33 the novel IL-1-family member is a potent mast cell activator. ML Castellani, D Kempuraj, V Salini, J Vecchiet, S Tete, C Ciampoli, ... Journal of biological regulators and homeostatic agents 23 (1), 11-14, 2009 | 36 | 2009 |
pio contiProfessor of Immunology, University of Chieti, Affiliated Professor, TUFTS University, Boston在 unich.it 的电子邮件经过验证
